Lisata Therapeutics, Inc. (LSTA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.55+$0.0500 (+3.33%) on the dayAs of the close; data may be delayed.
LSTA price, last 12 months
Key stats
- Previous close
- $1.50
- Open
- $1.54
- Day range
- $1.49 – $1.55
- 52-week range
- $0.9875 – $5.07
- Volume
- 45K
- Avg volume (20 days)
- 318.6K
- Market cap
- $17.1M
Performance
1W−8.8%
1M−14.4%
3M−53.9%
6M−69.1%
YTD−16.7%
1Y−34.0%
vs S&P 500, 1Y−50.8 pts
Technicals and fundamentals
About Lisata Therapeutics, Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $17.1M